Navigation Links
Molecular Imaging, Inc. Announces New Webinar: Advancing Discovery and Development of Biologics Through Non-Invasive Biodistribution Imaging

Ann Arbor, MI (PRWEB) September 05, 2013

The free webinar, which will take place on September 10, 2013 at 11am ET, will feature presentations by Patrick McConville, Chief Scientific Officer of Molecular Imaging, and Maria Vosjan of BV Cyclotron VU.

Dr. McConville will review the dual labeling and imaging strategy and related challenges. He will provide an overview of the key imaging technologies involved, and how these technologies can be accessed and used to drive key decision-making associated with assessment of biologics targeting and biodistribution. Dr. Vosjan will present an overview of immuno-PET imaging of targeting and non-invasive biodistribution. She will focus on zirconium-89 and iodine-124 PET based detection and imaging of labeled antibodies, including preclinical and clinical imaging success stories.

“In vivo biodistribution imaging studies are increasingly enhancing the discovery and development of new biologic and pharmaceutical molecules. Attendees of this webinar can expect to gain a greater understanding of the need, challenges, and execution of the imaging in these biodistribution studies including PET, SPECT, and in vivo fluorescence tomography," said Molecular Imaging CSO, Patrick McConville.

Tuesday, September 10, 2013
11am ET
Duration: 1 hour
Click here for additional information and to register.

About Molecular Imaging, Inc.
Molecular Imaging, Inc. is a specialty contract research organization (CRO) located in Ann Arbor, Michigan. Molecular Imaging employs a wide array of imaging technologies, including MRI, micro-CT, micro-PET, SPECT and optical (two-dimensional and fluorescence molecular tomography) to quantitatively assess test agent performance at anatomical, functional and molecular levels. Molecular Imaging Inc. also conducts applications research to develop and optimize the use of imaging and actively seeks collaborations to further advance imaging in the field of drug discovery.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Janina A. Longtine, MD of the Icahn School of Medicine at Mount Sinai Elected President of the Association for Molecular Pathology
2. Dartmouth researchers develop molecular switch that changes liquid crystal colors
3. Mount Sinai and Exosome Partner to Accelerate Translation of Body Fluid Molecular Diagnostics to Overcome Limitations of Tissue Biopsy in Areas of Unmet Medical Needs
4. Molecular Diagnostics Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research
5. New study shows vitamin D-related molecular switches predict childhood bone mass
6. Publishes 64 Thousand New Animal Science References and Bibliography on Molecular Cloning
7. Molecular switch controls the destiny of self-eating cells
8. The Association for Molecular Pathology announces 2013 Leadership Award recipient
9. Abnormalities in new molecular pathway may increase breast cancer risk
10. Researchers gain new molecular-level understanding of the brains recovery after stroke
11. Molecular imaging enlists prostate enzyme to detect metastases
Post Your Comments:
(Date:11/27/2015)... Chicago, IL (PRWEB) , ... November 27, 2015 ... ... some of the largest, most successful and prominent nonprofit healthcare organizations in the ... and governance involvement with various organizations, and helped advance the healthcare industry as ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... Avid collector, ... Ann Arbor Michigan boxing style concert posters. This is one of Joplin's most famous ... Canterbury House at the University of Michigan in Ann Arbor. The According to Hawley, ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... located in central Michigan, have come together on Thanksgiving Day to share the ... available for viewing on the Serenity Point YouTube channel, patients displayed what they ...
(Date:11/26/2015)... ... November 26, 2015 , ... CognisantMD ... for diagnostic imaging in the Waterloo region. Using the Ocean Platform, family physicians ... directly from their electronic medical record (EMR) without the need for redundant patient ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent Applied Drug ... need to integrate dose form selection in early phase drug development. The first ... supporting and bringing together the UK’s emerging life sciences companies, corporate partners, and ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , Países Bajos, November 26, 2015 ... la terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... la inmunoterapia con la terapia fotodinámica de Bremachlorin para ... Un nuevo enfoque combina la inmunoterapia con la terapia ... Clinical Cancer Research . --> ...
(Date:11/26/2015)... November 26, 2015 --> ... use SyMRI to find optimal contrast weighting of MRI ... and has signed a research agreement with SyntheticMR in order ... Using SyMRI, it is possible to generate multiple contrast images ... the patient has left, thus making it possible to both ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 /PRNewswire/ ... the addition of the "2016 Future ... Drugs of Abuse Testing Market: Supplier Shares, ... report to their offering. --> ... of the "2016 Future Horizons and ...
Breaking Medicine Technology: